Zeemont 5mg/10mg Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, indicated for the management of allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation non-sedating antihistamine, selectively antagonizes peripheral H1 receptors, thereby alleviating symptoms like sneezing, nasal congestion, and itching. Montelukast, a leukotriene receptor antagonist, inhibits the action of cysteinyl leukotrienes involved in inflammatory pathways, contributing to the reduction of bronchoconstriction and airway inflammation. The synergistic effect of these agents provides comprehensive relief from allergic symptoms by targeting multiple inflammatory mediators. Zeemont is typically prescribed for adults and pediatric patients over 15 years of age, with dosage and duration tailored according to clinical response and severity of symptoms. It is generally well tolerated; however, patients should be monitored for potential adverse effects such as headache, fatigue, gastrointestinal disturbances, or neuropsychiatric events. Caution is advised in patients with hepatic or renal impairment. Zeemont should be used under medical supervision, and patients are advised to adhere to prescribed dosing schedules to optimize therapeutic outcomes and minimize risks.